| Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆ J Arends, F Strasser, S Gonella, TS Solheim, C Madeddu, P Ravasco, ... ESMO open 6 (3), 100092, 2021 | 378 | 2021 |
| Inflammation and ovarian cancer A Macciò, C Madeddu Cytokine 58 (2), 133-147, 2012 | 365 | 2012 |
| The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study A Macciò, C Madeddu, G Gramignano, C Mulas, L Tanca, MC Cherchi, ... haematologica 100 (1), 124, 2015 | 299 | 2015 |
| Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites G Mantovani, A Macciò, L Mura, E Massa, MC Mudu, C Mulas, MR Lusso, ... Journal of molecular medicine 78, 554-561, 2000 | 285 | 2000 |
| Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia G Mantovani, A Macciò, C Madeddu, R Serpe, E Massa, M Dessì, ... The Oncologist 15 (2), 200-211, 2010 | 266 | 2010 |
| Managing cancer-related anorexia/cachexia G Mantovani, A Macciò, E Massa, C Madeddu Drugs 61, 499-514, 2001 | 261 | 2001 |
| Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy G Gramignano, MR Lusso, C Madeddu, E Massa, R Serpe, L Deiana, ... Nutrition 22 (2), 136-145, 2006 | 241 | 2006 |
| Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach C Madeddu, G Gramignano, G Astara, R Demontis, E Sanna, V Atzeni, ... Frontiers in physiology 9, 1294, 2018 | 222 | 2018 |
| Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers G Mercuro, C Cadeddu, A Piras, M Dessi, C Madeddu, M Deidda, ... The oncologist 12 (9), 1124-1133, 2007 | 200 | 2007 |
| Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status G Mantovani, A Macciò, C Madeddu, L Mura, G Gramignano, MR Lusso, ... International Journal of Cancer 98 (1), 84-91, 2002 | 195 | 2002 |
| A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in … G Mantovani, A Macciò, C Madeddu, G Gramignano, MR Lusso, R Serpe, ... Cancer Epidemiology Biomarkers & Prevention 15 (5), 1030-1034, 2006 | 189 | 2006 |
| Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment C Cadeddu, A Piras, G Mantovani, M Deidda, M Dessì, C Madeddu, ... American heart journal 160 (3), 487. e1-487. e7, 2010 | 188 | 2010 |
| Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment G Mantovani, C Madeddu, A Maccio, G Gramignano, MR Lusso, E Massa, ... Cancer Epidemiology Biomarkers & Prevention 13 (10), 1651-1659, 2004 | 181 | 2004 |
| Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia G Mantovani, A Macciò, C Madeddu, R Serpe, G Antoni, E Massa, ... Journal of molecular medicine 88, 85-92, 2010 | 171 | 2010 |
| Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia A Maccio, C Madeddu, D Massa, MC Mudu, MR Lusso, G Gramignano, ... Blood 106 (1), 362-367, 2005 | 167 | 2005 |
| A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles … A Macciò, C Madeddu, G Gramignano, C Mulas, C Floris, E Sanna, ... Gynecologic oncology 124 (3), 417-425, 2012 | 160 | 2012 |
| Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of … G Mantovani, A Macciò, C Madeddu, L Mura, G Gramignano, MR Lusso, ... Journal of molecular medicine 81, 664-673, 2003 | 160 | 2003 |
| Randomized phase III clinical trial of a combined treatment with carnitine+ celecoxib±megestrol acetate for patients with cancer-related anorexia/cachexia syndrome C Madeddu, M Dessì, F Panzone, R Serpe, G Antoni, MC Cau, ... Clinical nutrition 31 (2), 176-182, 2012 | 156 | 2012 |
| Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients A Macciò, G Gramignano, MC Cherchi, L Tanca, L Melis, C Madeddu Scientific reports 10 (1), 6096, 2020 | 152 | 2020 |
| Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications A Macciò, C Madeddu The Scientific World Journal 11 (1), 2020-2036, 2011 | 152 | 2011 |
